Join to View Full Profile
2589 Samaritan Dr4th Floor ClinicSan Jose, CA 95124
Phone+1 408-426-4900
Fax+1 669-233-2482
Dr. Galatin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am board-certified in Hematology, Medical Oncology, and Internal Medicine. I have been a staff hematologist/oncologist at Stanford Health Care's Cancer Center South Bay in San Jose, CA since mid-2015. In addition to having a very busy clinical practice, I am site physician superuser, working with clinical and IT partners to implement additional features in our EHR that enhance hematology/oncology workflows.
I have experience in conducting clinical trials, also have a deep background in drug discovery, having conducted doctoral and postdoctoral-level medicinal chemistry research.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2005 - 2008
Sutter Health/California Pacific Medical CenterResidency, Internal Medicine, 2002 - 2005
Virginia Commonwealth University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Publications & Presentations
PubMed
- 7 citationsDistress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid ...Joel W. Neal, Mohana Roy, Kelly Bugos, Christopher Sharp, Peter S. Galatin
JCO Oncology Practice. 2021-04-08 - 7 citationsPhase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignanciesPeter S. Galatin, Ranjana H. Advani, George A. Fisher, Brian Francisco, Thomas Julian
Investigational New Drugs. 2011-10-01 - 70 citationsA Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing CellsPeter S. Galatin, Donald J. Abraham
Journal of Medicinal Chemistry. 2004-07-21
Other Languages
- Russian, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
